PharmaTher Signs Exclusive Worldwide License Agreement for
PharmaTher to file ANDA and 505(b)(2) regulatory submissions with the FDA for novel uses, delivery forms and formulations of ketamine for mental health,...
Lou Gehrig Jean Christophe Monbaliu Fabio Chianelli Ketamine Technology Pharmather Holdings Ltd Neither The Canadian Securities Exchange
Source: globenewswire.com